3-溴甲基苯基硼酸, 新戊二醇酯 | 143805-78-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-溴甲基苯基硼酸, 新戊二醇酯
• 中文别名: 3-溴甲基苯基硼酸,新戊二醇酯；3-(溴甲基)苯硼酸新戊二醇酯；3-溴甲基苯硼酸新戊二醇酯
• 英文名称: 2-[4-(bromomethyl)phenyl]-5,5-dimethyl-1,3,2-dioxaborane
• 英文别名: 2-(4-(bromomethyl)phenyl)-5-5-dimethyl-1,3,2-dioxaborinane；2-(4-(Bromomethyl)phenyl)-5,5-dimethyl-1,3,2-dioxaborinane；2-[4-(bromomethyl)phenyl]-5,5-dimethyl-1,3,2-dioxaborinane
• CAS: 143805-78-1
• 化学式: C₁₂H₁₆BBrO₂
• 分子量: 282.973
• InChiKey: HIJSVCZXPKJRHJ-UHFFFAOYSA-N

物化性质

• 熔点：
  86-90
• 沸点：
  358.4±25.0 °C(Predicted)
• 密度：
  1.29±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.35
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2931900090
• 包装等级：
  II
• 危险类别：
  8
• 危险性防范说明：
  P260,P264,P270,P271,P280,P301+P330+P331,P303+P361+P353,P304+P340,P305+P351+P338,P310,P363,P403+P233,P405,P501
• 危险品运输编号：
  3261
• 危险性描述：
  H302,H335,H314
• 储存条件：
  存于室温、干燥且密封的环境中。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 3-Bromomethylphenylboronic acid, neopentyl glycol ester
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromomethylphenylboronic acid, neopentyl glycol ester
CAS number: 143805-78-1

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H16BBrO2
Molecular weight: 283.0

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴甲基苯基硼酸, 新戊二醇酯 在 盐酸 、 水 、 potassium carbonate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 24.5h， 生成 (R)-(4-(((3'-hydroxy-3-oxo-3H-spiro[isobenzofuran-1,9'-xanthen]-6'-yl)oxy)methyl)phenyl)boronic acid
  参考文献：
  名称：

  Design of a “Turn-Off/Turn-On” Biosensor: Understanding Carbohydrate-Lectin Interactions for Use in Noncovalent Drug Delivery

  摘要：

  A low-cost and highly sensitive biosensor system is designed to investigate carbohydrate-lectin interactions. This combination of glyco-gold nanoparticles and boronic acid biosensor system opens a way to study noncovalent drug delivery.

  DOI：

  10.1021/ja306288p
• 作为产物：
  描述：

  4-甲基苯硼酸新戊基二醇酯 在 N-溴代丁二酰亚胺(NBS) 作用下， 以 四氯化碳 为溶剂， 反应 12.0h， 以89%的产率得到3-溴甲基苯基硼酸, 新戊二醇酯
  参考文献：
  名称：

  Design of a “Turn-Off/Turn-On” Biosensor: Understanding Carbohydrate-Lectin Interactions for Use in Noncovalent Drug Delivery

  摘要：

  A low-cost and highly sensitive biosensor system is designed to investigate carbohydrate-lectin interactions. This combination of glyco-gold nanoparticles and boronic acid biosensor system opens a way to study noncovalent drug delivery.

  DOI：

  10.1021/ja306288p

文献信息

• Sensitive and selective method and device for the detection of trace amounts of a substance
  申请人：Dayagi Y. Yohai

  公开号：US20070117983A1

  公开（公告）日：2007-05-24

  A piezoelectric crystal element and a sensor utilizing the same are presented for use in a sensor device for identifying at least one foreign material from environment. The crystal element comprises at least one crystal resonator in the form of a inverted mesa structure, which has a membrane-like region and has a certain resonance frequency value. A surface region of the crystal resonator is modified by reactive molecules of a kind capable of interacting with the foreign material to yield a reaction product that effects a change in the resonance frequency of the crystal resonator from said certain resonance frequency value. This change is indicative of the identity and quantity of the foreign material.

  提供了一种压电晶体元件和利用该元件的传感器，用于用于识别环境中至少一种外部材料的传感器装置。晶体元件包括至少一个晶体谐振器，其呈倒置台形结构，具有类似薄膜的区域，并具有特定的共振频率值。晶体谐振器的表面区域通过能够与外部材料相互作用以产生影响晶体谐振器的共振频率从所述特定共振频率值变化的反应产物的反应分子进行修改。这种变化表明了外部材料的身份和数量。
• <i>N</i>-Benzylpolyamines as Vectors of Boron and Fluorine for Cancer Therapy and Imaging:  Synthesis and Biological Evaluation
  作者：Bénédicte Martin、Françoise Possémé、Caroline Le Barbier、François Carreaux、Bertrand Carboni、Nikolaus Seiler、Jacques-Philippe Moulinoux、Jean-Guy Delcros

  DOI：10.1021/jm010897q

  日期：2001.10.1

  N-benzyl derivatives of the polyamines as vectors of (10)B and (18)F for boron neutron capture therapy (BNCT) and tumor imaging by positron emission tomography (PET), respectively. In the present work, the synthesis, transport characteristics, DNA-binding properties, and cytotoxicity of several N-benzyl derivatives of putrescine and spermidine are described. The fluorinated spermidine derivative N-(3-

  癌细胞具有高亲和力的多胺吸收系统，但结构特征的严格性较低。因此，腐胺，亚精胺和亚精胺被认为是在治疗或诊断上有用的结构和元件在肿瘤中选择性积累的潜在载体。我们设想多胺的N-苄基衍生物分别作为（10）B和（18）F的载体，用于硼中子俘获治疗（BNCT）和通过正电子发射断层扫描（PET）进行肿瘤成像。在本工作中，描述了几种腐胺和亚精胺的N-苄基衍生物的合成，转运特性，DNA结合特性和细胞毒性。氟化亚精胺衍生物N-（3-[（[4-氨基丁基）氨基]丙基）[（4-氟苯基）甲基]胺（N（1）-4-Fbz-spd）可能因其高积累而用于PET通过多胺转运系统在癌细胞中 在含硼的苄基多胺中，N-（4-氨基丁基）（[4-（二羟基硼基）苯基]甲基）胺（4-Bbz-put）和N-（3-[（4-氨基丁基）氨基]丙基） （[4-（二羟基硼基）苯基]甲基）胺（N（1）-4-Bbz-spd）应该适用于BNCT，因为它们在B
• Biphenyl-tetrazole intermediate compounds
  申请人：Zeneca Limited

  公开号：US05420292A1

  公开（公告）日：1995-05-30

  The invention provides a novel chemical process for the manufacture of quinoline, pyridine and imidazole derivatives of the formula IV wherein Q, Y.sup.1 and Y.sup.2 have the various meanings defined herein, and their non-toxic salts, which are angiotensin II inhibitors. The process involves the removal of an electron-deficient phenyl group or a pyridyl or pyrimidyl group from a compound of the formula VI as defined herein. Certain of the intermediates are novel and are provided as a further feature of the invention.

  本发明提供了一种新的化学过程，用于制造式IV的喹啉、吡啶和咪唑衍生物，其中Q、Y.sup.1和Y.sup.2具有本文所定义的各种含义，以及它们的非毒性盐，它们是血管紧张素II抑制剂。该过程涉及从式VI所定义的化合物中去除一个电子不足的苯基或吡啶基或嘧啶基。其中某些中间体是新的，并作为本发明的另一特征提供。
• Heterocyclic boron compounds as intermediates for angiotensin II
  申请人：Imperial Chemical Industries PLC

  公开号：US05245035A1

  公开（公告）日：1993-09-14

  The invention concerns novel boron compounds of the formula IV, in which Q, Y.sup.1, G.sup.1 and G.sup.2 have the various meanings defined herein, and their acid and base addition salts. The said compounds are useful in the manufacture of certain quinoline, pyridine and imidazole derivatives which have angiotensin II inhibitory activity. The invention also provides novel processes for the production of the quinoline, pyridine and imidazole derivatives. ##STR1##

  本发明涉及一种新型的硼化合物，其化学式为IV，其中Q、Y1、G1和G2具有本文中定义的不同含义，以及它们的酸和碱盐。所述化合物在制造某些喹啉、吡啶和咪唑衍生物方面有用，这些衍生物具有血管紧张素II抑制活性。本发明还提供了制备喹啉、吡啶和咪唑衍生物的新方法。##STR1##
• Chemical process for making angiotesin II antagonist compounds
  申请人：Imperial Chemical Industries PLC

  公开号：US05294716A1

  公开（公告）日：1994-03-15

  The invention provides a novel chemical process for the manufacture of quinoline, pyridine and imidazole derivatives of the formula IV wherein Q, Y.sup.1 and Y.sup.2 have the various meanings defined herein, and their non-toxic salts, which are angiotensin II inhibitors. The process involves the removal of an electron-deficient phenyl group or a pyridyl or pyrimidyl group from a compound of the formula VI as defined herein.

  该发明提供了一种新的化学工艺，用于制造式IV的喹啉，吡啶和咪唑衍生物，其中Q，Y.sup.1和Y.sup.2具有在此定义的各种含义，以及其无毒盐，它们是血管紧张素II抑制剂。该工艺涉及从式VI所定义的化合物中去除一个电子不足的苯基或吡啶基或嘧啶基。